Location: NEW YORK, NY
CIK: 0001633313 · Show all filings
Period: Q1 2023 (← Previous) (Next →)
Filing Date: May 15, 2023
Total Value ($000): $6,745,178 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | HORIZON THERAPEUTICS PLC | 7,000,000 | $763,980 | 11.3% | $66.26 | — | Common | G46188101 |
| APLS | APELLIS PHARMACEUTICALS INC | 11,111,111 | $732,889 | 10.9% | $48.71 | +18.5% | Common | 03753U106 |
| UTHR | UNITED THERAPEUTICS CORP | 2,870,000 | $642,765 | 9.5% | $133.73 | +84.3% | Common | 91307C102 |
| SRPT | SAREPTA THERAPEUTICS INC | 3,650,000 | $503,080 | 7.5% | $101.47 | +27.8% | Common | 803607100 |
| ARGX | ARGENX SE | 1,287,500 | $479,697 | 7.1% | $140.84 | — | Sponsored ADR | 04016X101 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 1,666,666 | $403,767 | 6.0% | $118.73 | +129.5% | Common | 558868105 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 3,945,000 | $383,612 | 5.7% | $85.62 | +21.1% | Common | 09061G101 |
| — | SEAGEN INC | 1,801,906 | $364,832 | 5.4% | $146.25 | — | Common | 81181C104 |
| ASND | ASCENDIS PHARMA | 3,325,000 | $356,507 | 5.3% | $123.27 | — | Sponsored ADR | 04351P101 |
| FOLD | AMICUS THERAPEUTICS INC | 27,300,000 | $302,757 | 4.5% | $10.47 | +17.8% | Common | 03152W109 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 1,105,000 | $221,354 | 3.3% | $153.75 | +36.7% | Common | 02043Q107 |
| — | MIRATI THERAPEUTICS INC | 5,555,555 | $206,556 | 3.1% | $53.82 | — | Common | 60468T105 |
| XENE | XENON PHARMACEUTICALS INC | 4,900,000 | $175,371 | 2.6% | $16.29 | +126.8% | Common | 98420N105 |
| — | IVERIC BIO INC | 6,800,000 | $165,444 | 2.5% | $8.28 | — | Common | 46583P102 |
| KRYS | KRYSTAL BIOTECH INC | 1,750,000 | $140,105 | 2.1% | $66.44 | +18.3% | Common | 501147102 |
| KYMR | KYMERA THERAPEUTICS INC | 3,855,000 | $114,224 | 1.7% | $31.77 | +1.5% | Common | 501575104 |
| — | DICE THERAPEUTICS INC | 3,950,000 | $113,168 | 1.7% | $28.94 | — | Common | 23345J104 |
| — | CYMABAY THERAPEUTICS INC | 10,300,000 | $89,816 | 1.3% | $6.26 | — | Common | 23257D103 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 10,420,000 | $86,903 | 1.3% | $11.88 | -19.0% | Common | 09058V103 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 2,650,000 | $55,968 | 0.8% | $21.05 | +18.1% | Common | 87164F105 |
| NUVL | NUVALENT INC | 1,888,888 | $49,281 | 0.7% | $28.81 | +2.7% | Common | 670703107 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 7,020,000 | $42,892 | 0.6% | $16.40 | -57.9% | Common | 462260100 |
| RNAM | AVIDITY BIOSCIENCES INC | 2,510,000 | $38,529 | 0.6% | $21.47 | +2.5% | Common | 05370A108 |
| KURA | KURA ONCOLOGY INC | 3,105,000 | $37,974 | 0.6% | $23.38 | -46.6% | Common | 50127T109 |
| MNKD | MANNKIND CORP | 9,100,000 | $37,310 | 0.6% | $3.56 | +35.7% | Common | 56400P706 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 4,325,000 | $33,692 | 0.5% | $17.56 | -60.4% | Common | 61225M102 |
| — | MERSANA THERAPEUTICS INC | 7,550,000 | $31,031 | 0.5% | $21.34 | — | Common | 59045L106 |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 750,000 | $30,075 | 0.4% | $64.00 | -33.0% | Common | 90400D108 |
| — | MARINUS PHARMACEUTICALS INC | 3,150,000 | $21,735 | 0.3% | $12.20 | — | Common | 56854Q200 |
| WHWK | AADI BIOSCIENCES INC | 2,849,402 | $20,630 | 0.3% | $24.27 | -56.0% | Common | 00032Q104 |
| DSGN | DESIGN THERAPEUTICS INC | 3,500,000 | $20,195 | 0.3% | $19.27 | -61.2% | Common | 25056L103 |
| — | VERRICA PHARMACEUTICALS INC | 2,650,000 | $17,225 | 0.3% | $6.50 | — | Common | 92511W108 |
| PMVP | PMV PHARMACEUTICALS INC | 3,060,000 | $14,596 | 0.2% | $25.09 | -71.9% | Common | 69353Y103 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 473,100 | $13,881 | 0.2% | $24.95 | +39.2% | Common | 03237H101 |
| FENC | FENNEC PHARMACEUTICALS INC | 1,200,000 | $9,984 | 0.1% | $9.85 | -5.9% | Common | 31447P100 |
| — | SERES THERAPEUTICS INC | 1,295,000 | $7,343 | 0.1% | $5.67 | — | Common | 81750R102 |
| TNGX | TANGO THERAPEUTICS INC | 1,640,000 | $6,478 | 0.1% | $11.71 | -50.5% | Common | 87583X109 |
| IOBT | IO BIOTECH INC | 2,055,883 | $3,845 | 0.1% | $9.66 | -74.2% | Common | 449778109 |
| SRPT | SAREPTA THERAPEUTICS INC | 250,000 | $3,675 | 0.1% | $101.47 | +27.8% | Call | 803607100 |
| — | IVERIC BIO INC | 875,000 | $1,838 | 0.0% | $8.28 | — | Call | 46583P102 |
| XBI | SPDR SERIES TRUST - S&P BIOTECH | 1,500,000 | $180 | 0.0% | — | — | Call | 78464A870 |